Equity Capital Markets

Company · CIK 1860871

Tevogen Inc.

CIK1860871 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressNJ
ListedTVGN (Nasdaq), TVGNW (Nasdaq)
First annual or quarterly report2021-12-17

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-296760
ShelfEffective
 2026-06-122026-06-252
333-288218
ShelfEffective
 2025-06-202025-07-033
333-280414
Registered companyEffective
 2024-06-212025-05-025
333-260113
IPOFinal prospectus
 2021-10-072021-11-057

Filings

19
FiledFilingRegistrationAccession
2026-06-25EFFECTDeclared effective 333-2967609999999995-26-002124
2026-06-12S-3Shelf registered 333-2967600001493152-26-028495
2025-07-03424B5Shelf takedown 333-2882180001641172-25-017863
2025-06-26EFFECTDeclared effective 333-2882189999999995-25-002044
2025-06-20S-3Shelf registered 333-2882180001641172-25-015914
2025-05-02EFFECTDeclared effective 333-2804149999999995-25-001383
2024-08-02EFFECTDeclared effective 333-2804149999999995-24-002368
2024-08-01S-1/AAmendment 333-2804140001493152-24-029808
2024-07-23S-1/AAmendment 333-2804140001493152-24-028834
2024-06-21S-1Registration filed 333-2804140001493152-24-024790
2024-01-04EFFECTDeclared effective 333-2745199999999995-24-000042
2021-11-05424B4Final prospectus 333-2601130001104659-21-135071
2021-11-03EFFECTDeclared effective 333-2601139999999995-21-004173
2021-10-29S-1/AAmendment 333-2601130001104659-21-131285
2021-10-27S-1/AAmendment 333-2601130001104659-21-130391
2021-10-26S-1/AAmendment 333-2601130001104659-21-130064
2021-10-22S-1/AAmendment 333-2601130001104659-21-129086
2021-10-07S-1Registration filed 333-2601130001104659-21-124178
2021-06-10DRSDraft made public 377-050010000950123-21-007703

All filings of this company · CSV